IDEXX Laboratories
Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About IDXX
IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.
IDXX Key Statistics
Stock Snapshot
As of today, IDEXX Laboratories(IDXX) shares are valued at $553.47. The company's market cap stands at 43.81B, with a P/E ratio of 40.10.
On 2026-08-14, IDEXX Laboratories(IDXX) stock moved within a range of $552.93 to $569.14. With shares now at $553.47, the stock is trading +0.1% above its intraday low and -2.8% below the session's peak.
Trading volume for IDEXX Laboratories(IDXX) stock has reached 132.03K, versus its average volume of 760.81K.
The stock's 52-week range extends from a low of $518.55 to a high of $769.98.
The stock's 52-week range extends from a low of $518.55 to a high of $769.98.
IDXX News
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Idexx Laboratories, with a price target of $665.00. Unlo...
IDEXX Laboratories has had a weak run over the past five years, yet the current checks suggest the stock is not obviously cheap, with the Discounted Cash Flow (...
...
Analyst ratings
53%
of 17 ratingsMore IDXX News
IDEXX Laboratories (NasdaqGS:IDXX) has launched the Catalyst proBNP Test, the first dual-species point-of-care NT-proBNP cardiac assay for companion animals. T...
Image source: The Motley Fool. Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Of...
IDEXX Laboratories (IDXX) announced the launch of the Catalyst proBNP Test, expanding cardiac capabilities across its connected point-of-care and reference labo...
Barclays analyst Glen Santangelo lowered the firm’s price target on Idexx Laboratories (IDXX) to $710 from $800 and keeps an Overweight rating on the shares. Th...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.